Led by the health insurance reform law, a flurry of drug and food recalls, key medical breakthroughs and plenty of layoffs and lawsuits, 2010 proved to be an exciting — if not always positive — year. Here’s our rundown of the…
Tylenol and Band-Aid maker Johnson & Johnson announced on Tuesday that its sales declined 0.7% to $15 billion in the third quarter, compared to the same quarter last year, as domestic sales were “significantly impacted” by rece…
In testimony before Congress Thursday, Johnson & Johnson’s CEO apologized for the problems that have beset his company, including the quality issues with its children’s medicines and the “phantom recall” of a batch of Motrin. …